As a consequence of these actions decreasing CXCR4 expression, migration capacity of NK cells toward the CXCR4 ligand SDF-1α decreased in vitro, which would be expected to reduce the potential of these cells to infiltrate BM compartments where malignancies such leukemia and myeloma reside. The gene discussed is CXCR4; the disease is plasma cell myeloma.